FINWIRES · TerminalLIVE
FINWIRES

Endeavour Group to Exit Non-Core Winery, Agricultural Assets, Cut Own Grape Production by Over 80% Following Review of Wine Portfolio; Shares Reach Lowest Point

By

Endeavour Group (ASX:EDV) said it plans to exit or sell non-core winery as well as agricultural assets, reduce its own grape production by over 80%, and concentrate investment on high-performing brands with proven retail demand within its Pinnacle Drinks business, according to a Wednesday statement.

This is expected to result in around 99% flexible sourcing of purchased bulk wine and grapes from the viticulture market.

It also plans to streamline production and packaging to a smaller number of high-scale sites. Winery operations will be consolidated from seven sites to three, with Cape Mentelle in Western Australia, the Dorrien Estate in South Australia, and the Isabel Estate in New Zealand being retained.

It will seek a new owner for the Oakridge brand and operation in the Yarra Valley. The Chapel Hill, Riddoch Coonawarra, and Krondorf Barossa brands will be retained, but their vineyards and physical assets are expected to be sold. Chapel Hill operations will close at the end of June.

The firm does not intend to renew its lease of Josef Chromy, and assets associated with the business are under review.

A high-scale packaging facility will be retained at Vinpac Angaston in the Barossa Valley in South Australia. The Vinpac McLaren Vale bottling facility will close later in the year.

Endeavour Group's shares fell 4% in recent trading on Wednesday, reaching their lowest-ever point.

Related Articles

Asia

Alldigi Tech CFO Resigns; Successor Named

Alldigi Tech (NSE:ALLDIGI, BOM:532633) said Chief Financial Officer Avinash Jain has resigned, effective June 21, following his transition to a new role within the group/holding company, according to an Indian bourse filing on Tuesday.Shares of the company rose nearly 1% in early trade on Wednesday.The company appointed Manish Agarwal as its new CFO, effective June 22, the filing said.

$BOM:532633$NSE:ALLDIGI
Asia

CSPC Pharmaceutical's Profit Falls 42% in Q1

CSPC Pharmaceutical (HKG:1093) posted profit attributable to shareholders of 859.8 million yuan for the first quarter, down 42% from 1.48 billion yuan a year earlier, according to a Wednesday Hong Kong bourse filing.Earnings per share at the drugmaker came in at 0.0754 yuan from 0.1291 yuan in the prior-year period.Quarterly revenue fell 7.8% to 6.47 billion yuan from 7.01 billion yuan a year earlier.Despite the profit contraction, the company boosted its R&D spending by 7.7% to 1.403 billion Yuan, dedicating 26.8% of finished drug revenue to advance more than 130 clinical projects and accelerate its pipeline transition.

$HKG:1093
Asia

Update: BlueScope Steel No Longer Bidder for Whyalla Steelworks

(Updates to add BlueScope's response in the fourth and fifth paragraphs)BlueScope Steel (ASX:BSL) is no longer a bidder for Whyalla Steelworks operations in South Australia, multiple media outlets reported on Wednesday.South Australia Premier Peter Malinauskas said that two bidders have been shortlisted for the sale, according to his post on X.According to media reports, M Resources and India-listed Jindal Steel remain the last remaining bidders for the South Australian business.A Bluescope spokesperson, in response to' email request for comment, said that its consortium, together with Nippon Steel Corporation, JSW Steel, and POSCO, has been advised by the Administrators that it has not been invited to progress to the next stage of the process."The Administrator has confirmed that BlueScope retains its right of last offer under the services agreement[;] however, there remains no obligation on any of the consortium members to make an offer to acquire the Whyalla Steelworks," the spokesperson added.The company's shares rose 1% in recent Wednesday trade.

$ASX:BSL